Cargando…

Height and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial

BACKGROUND: The relationship between prostate cancer and height is uncertain. METHODS: We prospectively examined the association of height with prostate cancer among 34268 men in the prostate, lung, colorectal, and ovarian cancer trial. Anthropometry was assessed at baseline and 2144 incident prosta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, J, Moore, S C, Albanes, D, Huang, W-Y, Leitzmann, M F, Hayes, R B
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720230/ https://www.ncbi.nlm.nih.gov/pubmed/19568244 http://dx.doi.org/10.1038/sj.bjc.6605159

Ejemplares similares

Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
por: Leitzmann, Michael F., et al.
Publicado: (2008)

Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial
por: Huang, Jiaqi, et al.
Publicado: (2016)

Pigmentation-related phenotypes and risk of prostate cancer
por: Weinstein, S J, et al.
Publicado: (2013)

Metabolomic Analysis of Vitamin E Supplement Use in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
por: Lim, Jungeun, et al.
Publicado: (2023)

Acceptance of Cancer in Patients Diagnosed with Lung, Breast, Colorectal and Prostate Carcinoma
por: RELIGIONI, Urszula, et al.
Publicado: (2015)

Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort
por: Lacey, James V, et al.
Publicado: (2009)

Metabolomic Analysis of Renal Cell Carcinoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
por: McClain, Kathleen M., et al.
Publicado: (2022)

Association of body mass index and height with risk of prostate cancer among middle-aged Japanese men
por: Kurahashi, N, et al.
Publicado: (2006)

Association between coffee drinking and telomere length in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
por: Steiner, Bella, et al.
Publicado: (2020)

SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
por: Azzato, Elizabeth M, et al.
Publicado: (2009)

Brief report: Impact of healthcare quality on prostate specific antigen screening for the early detection of prostate cancer
por: Rezaee, Michael E., et al.
Publicado: (2019)

Randomization to Screening for Prostate, Lung, Colorectal and Ovarian Cancers and Thyroid Cancer Incidence in Two Large Cancer Screening Trials
por: O'Grady, Thomas J., et al.
Publicado: (2014)

Body mass index and mortality among blacks and whites in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
por: Xiao, Qian, et al.
Publicado: (2013)

Prediagnostic BMI trajectories in relation to pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
por: Hoyt, Margaret, et al.
Publicado: (2022)

Association of Dietary Carrot/Carotene Intakes With Colorectal Cancer Incidence and Mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
por: Jiang, Zongze, et al.
Publicado: (2022)

Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer
por: Nilsson, J, et al.
Publicado: (2009)

Calcium: magnesium intake ratio and colorectal carcinogenesis, results from the prostate, lung, colorectal, and ovarian cancer screening trial
por: Zhao, Jing, et al.
Publicado: (2019)

Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
por: Ferrucci, L M, et al.
Publicado: (2009)

Indications for additional volume studies for gland volume estimation in prostate cancer brachytherapy
por: Khanolkar, Rutvij A, et al.
Publicado: (2022)

Detection of prostate cancer by an FDG-PET cancer screening program: results from a Japanese nationwide survey
por: Minamimoto, Ryogo, et al.
Publicado: (2014)

Serum α-Tocopherol and γ-Tocopherol Concentrations and Prostate Cancer Risk in the PLCO Screening Trial: A Nested Case-Control Study
por: Weinstein, Stephanie J., et al.
Publicado: (2012)

The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort
por: Kawakita, Daisuke, et al.
Publicado: (2018)

White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
por: Sturgeon, Susan R., et al.
Publicado: (2017)

A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial
por: Falk, Roni T., et al.
Publicado: (2016)

Evaluation of Aspirin Use With Cancer Incidence and Survival Among Older Adults in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
por: Loomans-Kropp, Holli A., et al.
Publicado: (2021)

Childhood height, adult height, and the risk of prostate cancer
por: Bjerregaard, Lise Geisler, et al.
Publicado: (2016)

Genetic Variation on 9p22 Is Associated with Abnormal Ovarian Ultrasound Results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
por: Wentzensen, Nicolas, et al.
Publicado: (2011)

Dairy products, calcium and prostate cancer risk
por: Koh, K A, et al.
Publicado: (2006)

Hand pattern indicates prostate cancer risk
por: Rahman, A A, et al.
Publicado: (2011)

Nut consumption and prostate cancer risk and mortality
por: Wang, Weike, et al.
Publicado: (2016)

Prostate-specific membrane antigen can promote in vivo osseous metastasis of prostate cancer cells in mice
por: Zhao, Liang-Yun, et al.
Publicado: (2012)

Favourable response of serum prostate-specific antigen to conjugated oestrogen in castrate-resistant prostate cancer in Jamaica
por: Condappa, Andrew, et al.
Publicado: (2018)

Is Height of Prognostic Significance in Breast Cancer Cases?
por: Cihan, Yasemin Benderli
Publicado: (2017)

Diagnostic benefits of mindin as a prostate cancer biomarker: Dijagnostičke prednosti mindina kao biomarkera raka prostate
por: Hanousková, Lenka, et al.
Publicado: (2020)

Concordance of National Cancer Registration with self-reported breast, bowel and lung cancer in England and Wales: a prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening
por: Gentry-Maharaj, A, et al.
Publicado: (2013)

Heritable methylation marks associated with prostate cancer risk
por: Dowty, James G., et al.
Publicado: (2023)

Colorectal cancer screening utilization among breast, cervical, prostate, skin, and lung cancer survivors
por: Tsai, Meng-Han, et al.
Publicado: (2022)

Association of Aspirin Use With Mortality Risk Among Older Adult Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
por: Loomans-Kropp, Holli A., et al.
Publicado: (2019)

Relationship between vegetable and carotene intake and risk of prostate cancer: the JACC study
por: Umesawa, M, et al.
Publicado: (2014)

Associations between obesity, smoking and lymph node status at breast cancer diagnosis in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
por: Smith, Amelia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d2m2vranvrog26q2ibrojkq629